Palisade Bio (PALI) Restructuring Costs (2013 - 2026)

Palisade Bio (PALI) has 4 years of Restructuring Costs data on file, last reported at $4.2 million in Q1 2026.

• Restructuring Costs for Q1 2026 came in at $4.2 million, up 213.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (up 91.8% YoY), and the FY2025 annual result was $7.6 million, up 38.37% from the prior year.
• Restructuring Costs grew to $4.2 million in Q1 2026 per PALI's latest filing, from $3.6 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $4.2 million in Q1 2026 and troughed at $1.1 million in Q2 2025.
• A 3-year average of $1.9 million and a median of $1.4 million in 2024 frame the typical range for Restructuring Costs.
• The sharpest annual moves came in 2025 and 2026: Restructuring Costs fell 22.6% in 2025, then surged 213.14% in 2026.
• A 3-year view of Restructuring Costs shows it stood at $1.4 million in 2024, then surged by 158.13% to $3.6 million in 2025, then climbed by 18.15% to $4.2 million in 2026.
• Business Quant data shows PALI's Restructuring Costs at $4.2 million in Q1 2026, $3.6 million in Q4 2025, and $1.5 million in Q3 2025.